Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
mdpi.com A firstinhuman tolerability trial administering IV BPC-157 to healthy volunteers showed good safety profiles at doses up to 0.5 mg/kg, setting the stage for future clinical pharmacokinetic and safety assessments
No company currently has clear profit motive to spend millions funding human trials
AOD9604 may be used in laboratory studies involving: All uses are limited to research settings only
The mechanisms include reduction of excitotoxicity and oxidative stress, enhanced neurotrophic factor expression supporting neuronal survival, angiogenesis improving blood flow, and modulation of dopamine and serotonin systems
US$ 27.07
%20(1).png)
US$ 22.28
US$ 29.19
US$ 23.51
US$ 27.53
US$ 25.22
